The MCO-010 vector uses surviving cells in the retina to produce a photosensitive protein that may help patients regain some ...

Following up on previous, dimly received issuances, a new set of ideas published by the FDA to streamline regulatory pathways ...

Treatment introduces an expansion of the scope of gene therapies that might lead to similar treatments for neurodegenerative ...

After three patients died, the maker of an investigational gene therapy stopped shipments of the drug after it refused to ...

The Cell and Gene Therapy Catapult and pHion Therapeutics announced an exclusive licence agreement for pHion’s proprietary RALA technology for ex-vivo applications. The agreement builds upon the ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Preliminary results from a small trial offer the clearest evidence yet that the brain disease’s progression can be slowed.

Cirrus’ lead program is a novel AAV gene therapy designed to restore IRAK-M, a central regulator of the eye’s immune homeostasis, so as to ...

Stanford researchers and their collaborators have revealed a new device that could change the way scientists conduct ...

How cell and gene therapy developers can lessen the chances of receiving FDA complete response letters through the use of ...

Cayman Chemical, a global provider of life science research tools, and Akadeum Life Sciences, a leader in buoyancy-based cell ...

Universities must do more to provide students with cell and gene therapy manufacturing skills, according to a new study.